SEC Filing Details

SEC Filing Details

Document Details

Form

Filing Date

Mar 22, 2022

Document Date

Mar 17, 2022

Form Description

Amendment to a previously filed 8-K

Filing Group

Current Reports

Company

ReShape Lifesciences

Issuer

RESHAPE LIFESCIENCES INC.

Filing Formats

View HTML

XBRL

XBRL Viewer

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

EX-101.LAB - EX-101.LAB

EX-101.PRE - EX-101.PRE

XML - XBRL INSTANCE DOCUMENT

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE